Potent and selective inhibitor of both free and prothrombin-bound factor Xa, Ki = 0.8 nM.1 Clinically useful antithrombotic agent.2 Apixaban lowered risk of recurrent venous thromboembolism and major bleeding in high-risk patients.3
* VAT and and shipping costs not included. Errors and price changes excepted